MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

01 Nov 2025 Evaluate
The September 2025 quarter revenue stood at Rs. 112.36 millions, up 15.08% as compared to Rs. 97.64 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2025 is Rs. -8.37 millions as compared to Net Profit of Rs. 13.48 millions of corresponding quarter ended September 2024Operating profit for the quarter ended September 2025 rose to 29.90 millions as compared to 27.49 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 112.36 97.64 15.08 208.79 196.77 6.11 430.47 408.34 5.42
Other Income 7.00 3.44 103.49 12.88 6.81 89.13 15.49 10.04 54.28
PBIDT 29.90 27.49 8.77 60.40 65.22 -7.39 157.29 182.26 -13.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 30.40 40.97 -25.80 60.90 78.70 -22.62 176.52 182.26 -3.15
Depreciation 17.82 17.46 2.06 35.56 34.73 2.39 69.60 70.85 -1.76
PBT 12.58 23.51 -46.49 25.34 43.97 -42.37 106.92 111.41 -4.03
TAX 20.95 10.03 108.87 23.82 17.59 35.42 50.79 28.43 78.65
Deferred Tax 42.22 10.03 320.94 42.87 17.59 143.72 25.86 28.43 -9.04
PAT -8.37 13.48 -162.09 1.52 26.38 -94.24 56.13 82.98 -32.36
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 26.61 28.15 -5.48 28.93 33.15 -12.72 36.54 44.63 -18.14
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..